健康元药业集团股份有限公司关于为控股子公司提供担保进展情况的公告

Core Viewpoint - The company has entered into guarantee agreements with Ping An Bank to support its wholly-owned subsidiaries, ensuring their operational financing needs are met without any related guarantees or overdue situations [1][9][10]. Group 1: Guarantee Details - The total guarantee amounts for the subsidiaries are as follows: Shenzhen Haibin Pharmaceutical Co., Ltd. (RMB 200 million), Shenzhen Taotai Pharmaceutical Co., Ltd. (RMB 80 million), Jiaozuo Health Yuan Biological Products Co., Ltd. (RMB 200 million), and Health Yuan Haibin Pharmaceutical Co., Ltd. (RMB 100 million) [1]. - The company has approved a maximum credit financing of RMB 24.6 billion or equivalent foreign currency from banks, with a specific guarantee of up to RMB 20.201 billion for its subsidiaries [2][9]. - The guarantees provided are joint liability guarantees, with no counter-guarantees involved [5][6][7][8]. Group 2: Financial Health and Risk Management - As of August 31, 2025, the total guarantee balance of the company is RMB 2.834 billion, which represents 19.50% of the latest audited net assets attributable to shareholders [10]. - There are no overdue guarantees for the company or its subsidiaries, indicating a stable financial position and effective risk management [10].